JPH02292296A - マクロライド誘導体、その製造方法およびそれを含有する医薬組成物 - Google Patents

マクロライド誘導体、その製造方法およびそれを含有する医薬組成物

Info

Publication number
JPH02292296A
JPH02292296A JP2104346A JP10434690A JPH02292296A JP H02292296 A JPH02292296 A JP H02292296A JP 2104346 A JP2104346 A JP 2104346A JP 10434690 A JP10434690 A JP 10434690A JP H02292296 A JPH02292296 A JP H02292296A
Authority
JP
Japan
Prior art keywords
formula
group
derivative
formulas
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2104346A
Other languages
English (en)
Japanese (ja)
Inventor
Gabor Lukacs
ガボール　ルカクス
Catherine Duchatelle-Ruggeri
キャセリン　ドゥヤテル―リュゲリ
Alain Olesker
アライン　オレスケル
Li Ming
ミン リ
Sylvie Bobillot
シルビー　ボビロ
Ton Thatthang
トン　ササング
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Servier de Medecine Translationnelle SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of JPH02292296A publication Critical patent/JPH02292296A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2104346A 1989-04-20 1990-04-19 マクロライド誘導体、その製造方法およびそれを含有する医薬組成物 Pending JPH02292296A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8905246 1989-04-20
FR8905246A FR2646081A1 (enExample) 1989-04-20 1989-04-20

Publications (1)

Publication Number Publication Date
JPH02292296A true JPH02292296A (ja) 1990-12-03

Family

ID=9380938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2104346A Pending JPH02292296A (ja) 1989-04-20 1990-04-19 マクロライド誘導体、その製造方法およびそれを含有する医薬組成物

Country Status (10)

Country Link
US (1) US5043324A (enExample)
EP (1) EP0394135A1 (enExample)
JP (1) JPH02292296A (enExample)
AU (1) AU625201B2 (enExample)
CA (1) CA2014925A1 (enExample)
FR (1) FR2646081A1 (enExample)
NZ (1) NZ233378A (enExample)
OA (1) OA09447A (enExample)
PT (1) PT93807A (enExample)
ZA (1) ZA903008B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2067520A1 (en) * 1991-05-02 1992-11-03 Tats Matsuoka Treatment of mastitis
US5677287A (en) * 1993-03-18 1997-10-14 Pfizer Inc. Antibacterial 16-membered ring macrolides containing olefins at C-20
AU6980094A (en) * 1993-07-15 1995-02-13 Pfizer Inc. Amide derivatives of 16-membered ring antibiotic macrolides
EP0778283A3 (en) * 1995-12-05 1998-01-28 Pfizer Inc. Antibiotic macrolides
US6753415B2 (en) * 2002-04-19 2004-06-22 Enanta Pharmaceuticals, Inc. 23-O-substituted 5-O-mycaminosyltylonide derivatives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62113036U (enExample) * 1985-12-30 1987-07-18
JPH01147945U (enExample) * 1988-04-01 1989-10-13

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.
DE2939154C2 (de) 1979-09-27 1982-08-05 Neumünstersche Maschinen- und Apparatebau GmbH (Neumag), 2350 Neumünster Stapelfaserschneidmaschine
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62113036U (enExample) * 1985-12-30 1987-07-18
JPH01147945U (enExample) * 1988-04-01 1989-10-13

Also Published As

Publication number Publication date
AU625201B2 (en) 1992-07-02
FR2646081A1 (enExample) 1990-10-26
PT93807A (pt) 1990-11-20
AU5362890A (en) 1990-10-25
US5043324A (en) 1991-08-27
ZA903008B (en) 1991-01-30
CA2014925A1 (fr) 1990-10-20
EP0394135A1 (fr) 1990-10-24
OA09447A (fr) 1992-10-15
NZ233378A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
JP2992540B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用
Deutsch et al. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity
US4345069A (en) Deformyltylosin derivatives
KR100371473B1 (ko) 신규한에리스로마이신유도체,그의제조방법및의약으로서의용도
HU193886B (en) Process for preparing epimer azahomoerythromycin a derivatives
JP3101590B2 (ja) アジトロマイシン・２水和物の製法及びその中間体
MX2007014913A (es) Proceso para perparar clorhidrato de memantina sustancialmente libre de impurezas.
US4464527A (en) Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
CN111574575B (zh) 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用
JPH02240095A (ja) 環縮合型マクロライド化合物
CN110938114B (zh) 一类万古霉素硫鎓衍生物、其制备方法、药物组合物和用途
US5043324A (en) Macrolide compounds
CN109942654A (zh) 一种大环内酯和喹诺酮杂合物及其制备方法
CN113788796A (zh) 千金二萜烷分子拼合衍生物及其制备方法和用途
CN109942653B (zh) 一种红霉素衍生物及其制备方法
CN101074252B (zh) 11,12-环碳酸酯-阿奇霉素4＂-氨甲酸酯衍生物、制备方法及其药物组合物
JPS5896098A (ja) エリスロマイシンａ誘導体
DK159450B (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin b og farmaceutisk acceptable syreadditionssalte deraf samt 9-deoxo-9a-aza-9a-homoerythromycin b til anvendelse som mellemprodukt ved fremstilling deraf
US5032581A (en) Tylosin derivatives
EP0063489A1 (en) 4"-Modified methylene oleandomycins
EP0114486B1 (en) Alkylation of oleandomycin
JPH07196681A (ja) 新規なエリスロマイシン誘導体、その製造法及び薬剤としての使用
BG62333B1 (bg) Нови съединения от клас секомакролиди и секоазалиди и методза получаването им
JP2001507011A (ja) 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
CN106916194B (zh) 一种新型含有氨基的酮内酯衍生物、制备方法及应用